Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SpePharm raises €7mm to fund Savene deal

Executive Summary

European specialty pharmaceuticals company SpePharm Holding BV has raised €7mm ($9.6mm) in Series C money from existing investors TVM Capital, Signet Healthcare, and Paul Capital Healthcare. Funds from the late-stage round will be used for the company's concurrently announced acquisition of worldwide rights (excluding North and South America) to the anthracycline extravasation drug Savene from TopoTarget AS.
Deal Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies